Emerging Therapies for Diabetes (Technical Insights)

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

Descibes research and technology development highlights in the field of diabetes treatment.

Table of Contents

Emerging Therapies for Diabetes (Technical Insights), Executive SummaryScope and MethodologyScope and SegmentationMethodologyDiabetes--An OverviewTypes and Related Health ComplicationsUnderlying Causes; Symptomatic Diagnosis and Treatment ApproachKey FindingsEmerging Therapies for Diabetes (Technical Insights), Emerging Therapies in Diabetes - Technology AnalysisTechnology PrimerCurrent Diabetes TherapiesNoteworthy Emerging Diabetes Therapies Noteworthy DevelopmentsCorporate SectorResearch Institutions and UniversitiesFuture Trends; Strategic RecommendationsFuture TrendsAnalyst Views and Strategic RecommendationsEmerging Therapies for Diabetes (Technical Insights), Technology Adoption Factor AnalysisTechnology Drivers and RestraintsPharmacotherapyInsulin TherapyPancreas TransplantIslet Cell TransplantArtificial PancreasGene TherapyFunding Analysis; Alliances; Mergers and AcquisitionsFundingAlliances; Mergers; and AcquisitionsEmerging Therapies for Diabetes (Technical Insights), Assessment of Emerging Therapies and Screening Methods for Diabetes in Key Companies and UniversitiesTechnology Innovations in Companies--North America Breakthrough Inhalable Insulin Therapy Relieves People of Painful Injections--USANew Class of Oral Drugs for Diabetes--USAUnique Diabetic Drug Based on Drug Repositioning Strategy for Type 2 Diabetes--CanadaAntidiabetic Drugs Promote Natural Metabolism by Mimicking Natural Hormones--USAOral Insulin Spray for the Treatment of Diabetes--CanadaFast Acting Nasal Spray Formulation of Insulin for Diabetes Patients--USANovel Protein-Based Therapeutics for Treating Diabetes-Related Complications--USANoninvasive Screening Technology for Detecting Prediabetes and Diabetes--USAScreening for Diabetes through Diagnostic Imaging of the Retina--USANovel Drug for the Treatment of Type 1 Diabetes with Potential Long-Term Benefits--USAUnique Combination Drug for Patients with Type 2 Diabetes and Hypertension--CanadaNovel Combination Drug for Type 2 Diabetes--USANovel Small Molecule Drug Controls Blood Sugar without Causing Hypoglycemia--USADevelopment of Bioartificial Pancreas for the Treatment of Type 1 Diabetes--USAIntegrated and Compact Insulin Delivery System--USATechnology Innovations in Companies--EuropeNovel Drug Addresses the Twin Problem of Diabetes and Obesity--FranceNanotechnology-Based Insulin Pump for Pain-Free Delivery of Insulin--SwitzerlandNovel Range of Diabetes Care Products to Serve a Broader Patient Community--DenmarkNovel Antidiabetic Drug Targeting the Pancreatic Islet Dysfunction--SwitzerlandNovel Drug Preserves Beta Cell Function in Type 1 Diabetes--SwedenNovel Drugs that Treat Diabetes and its Complications Enter Clinical Trials--UKTechnology Innovations in Companies--APACHealthy Neonatal Porcine Islet Cell Transplantation Technology for Insulin Production--AustraliaNovel Peptide-Based Drug that Uniquely Targets Diabetes and its Resultant Complications--AustraliaTopical Human Insulin Product for both Type 1 and Type 2 Diabetes--AustraliaCombo Drugs Gaining Recognition for Treating Type 2 Diabetes--JapanTechnology Innovations in Universities--WorldIdentification of Potential Therapeutic Targets for Treatment of Metabolic Syndrome--USANew Method of Treating Diabetes Using a Naturally Occurring Fatty Acid--USANovel Designer Approach to Treat Type 1 Diabetes--USAUse of Chromium as an Adjunct in the Pharmaceutical Therapy of Diabetes--USAStudy Identifies the Role of Brain in Diabetes Therapy--USADelivering Insulin Genes through a Unique Mechanism Boosts Gene Therapy of Diabetes--USAEmerging Therapies for Diabetes (Technical Insights), Patents and Key ContactsPatentsUS PatentsEuropean PatentsKey ContactsCorporate ContactsUniversity ContactsEmerging Therapies for Diabetes (Technical Insights), Decision Support DatabaseBiotechnology--Companies; R&D; Funding--WorldNumber of Biotech Companies (2002-2012)Government R&D Investment in Biotechnology (2002-2012)Venture Capital Investment in Biotechnology (2002-2012)Population; Healthcare and Pharmaceutical R&D Expenditures--WorldTotal PopulationTotal Healthcare Expenditure Pharmaceutical R&D ExpenditurePrevalence of Diabetes and Related Health Risks--WorldDiabetes Incidence (2002-2012)Prevalence of Diabetes (2002-2012)Diabetes Foot Ulcer Prevalence (2002-2012)Obesity Prevalence (2002-2012)Cataract Blindness (2002-2012)Cardiovascular Prevalence (2002-2012)Organ Transplants--WorldNumber of Kidney Transplants (2000-2006)Number of Pancreas Transplants (2002-2006)




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 10-Nov-17

Region : Global

Release Date : 10-Nov-17

Region : Global

Release Date : 09-Nov-17

Region : Global

Release Date : 03-Nov-17

Region : Global

Release Date : 31-Oct-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.